Table 1. Advantage of the pooling approach.
Query Gene Set | ||
Blood Vessel Development Gene Set | 0.0698 | 0.2428 |
Bone Development Gene Set | 0.1930 | 0.4574 |
Brain Development Gene Set | 0.1252 | 0.2887 |
Heart Development Gene Set | 0.0990 | 0.2781 |
Kidney Development Gene Set | 0.1532 | 0.3507 |
Liver Development Gene Set | 0.2350 | 0.5632 |
Lung Development Gene Set | 0.1438 | 0.3460 |
Nerve Development Gene Set | 0.3296 | 0.6140 |
Skin Development Gene Set | 0.3007 | 0.5176 |
Average probabilities (over 100 trials) that random, withheld gene-disease links support nodes more significant by the traditional method () or the proposed pooling method () for the 9 query gene sets. Significance in each trial was computed without the withheld links. When is larger than , the nodes that are more significant under the pooling approach tend to be more consistently supported by the withheld data, our proxy for correctness.